Tech Company Financing Transactions

NovaCardia Funding Round

NovaCardia closed a $48 million Series B funding round on 9/29/2006. Investors included Skyline Ventures, Domain Associates and Forward Ventures.

Transaction Overview

Company Name
Announced On
9/29/2006
Transaction Type
Venture Equity
Amount
$48,000,000
Round
Series B
Investors

Skyline Ventures (Lead Investor) (David Lowe)

Domain Associates (Eckard Weber)

Forward Ventures (Stuart Collinson)

InterWest Partners (Nina Kjellson)

Montreux Equity Partners (Daniel Turner)

Versant Ventures (Camille Samuels)

Proceeds Purpose
The capital raised will support continued clinical development of KW-3902 and other cardiovascular compounds in NovaCardia's pipeline.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
12651 High Bluff Drive 200
San Diego, CA 92130
USA
Email Address
Not Recorded
Overview
NovaCardia is a product-focused pharmaceutical company with significant capabilities and experience in cardiovascular drug development.
Profile
NovaCardia LinkedIn Company Profile
Social Media
NovaCardia Company Twitter Account
Company News
NovaCardia News
Facebook
NovaCardia on Facebook
YouTube
NovaCardia on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Randall Woods
  Randall Woods LinkedIn Profile  Randall Woods Twitter Account  Randall Woods News  Randall Woods on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/28/2006: CoMentis venture capital transaction
Next: 9/29/2006: Twisted Pair Solutions venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary